Evidence-Based Medicine Guidelines
Intravesical bacillus Calmette-Guerin versus mitomycin C for bladder cancer.
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Intravesical Bacillus Calmette-Guerin Versus Mitomycin C for Bladder Cancer. ." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/454099/all/Intravesical_bacillus_Calmette_Guerin_versus_mitomycin_C_for_bladder_cancer_.
Intravesical bacillus Calmette-Guerin versus mitomycin C for bladder cancer. . Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/454099/all/Intravesical_bacillus_Calmette_Guerin_versus_mitomycin_C_for_bladder_cancer_. Accessed June 1, 2023.
Intravesical bacillus Calmette-Guerin versus mitomycin C for bladder cancer. . (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/454099/all/Intravesical_bacillus_Calmette_Guerin_versus_mitomycin_C_for_bladder_cancer_
Intravesical Bacillus Calmette-Guerin Versus Mitomycin C for Bladder Cancer [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 June 01]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/454099/all/Intravesical_bacillus_Calmette_Guerin_versus_mitomycin_C_for_bladder_cancer_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Intravesical bacillus Calmette-Guerin versus mitomycin C for bladder cancer.
ID - 454099
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/454099/all/Intravesical_bacillus_Calmette_Guerin_versus_mitomycin_C_for_bladder_cancer_
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
